These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39002498)

  • 21. Preparation of an Actinium-228 Generator.
    Aldrich KE; Lam MN; Eiroa-Lledo C; Kozimor SA; Lilley LM; Mocko V; Stein BW
    Inorg Chem; 2020 Mar; 59(5):3200-3206. PubMed ID: 32062965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of
    Robertson AKH; Ramogida CF; Schaffer P; Radchenko V
    Curr Radiopharm; 2018; 11(3):156-172. PubMed ID: 29658444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calculation of radium-223 and actinium-225 α-emitter radiopharmaceuticals dose rates in treatment of metastatic castration-resistant prostate cancer.
    Abbasi A; Dadashpour M; Alipourfard I
    J Cancer Res Ther; 2021; 17(2):348-352. PubMed ID: 34121676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV.
    Weidner JW; Mashnik SG; John KD; Hemez F; Ballard B; Bach H; Birnbaum ER; Bitteker LJ; Couture A; Dry D; Fassbender ME; Gulley MS; Jackman KR; Ullmann JL; Wolfsberg LE; Nortier FM
    Appl Radiat Isot; 2012 Nov; 70(11):2602-7. PubMed ID: 22940414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of lanthanum phosphate nanoparticles as carriers for (223)Ra and (225)Ra for targeted alpha therapy.
    Rojas JV; Woodward JD; Chen N; Rondinone AJ; Castano CH; Mirzadeh S
    Nucl Med Biol; 2015 Jul; 42(7):614-20. PubMed ID: 25900730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 225Ac and 223Ra production via 800 MeV proton irradiation of natural thorium targets.
    Weidner JW; Mashnik SG; John KD; Ballard B; Birnbaum ER; Bitteker LJ; Couture A; Fassbender ME; Goff GS; Gritzo R; Hemez FM; Runde W; Ullmann JL; Wolfsberg LE; Nortier FM
    Appl Radiat Isot; 2012 Nov; 70(11):2590-5. PubMed ID: 22944532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of poorly crystalline silicotitanate in production of
    Fitzsimmons J; Abraham A; Catalano D; Younes A; Cutler CS; Medvedev D
    Sci Rep; 2019 Aug; 9(1):11808. PubMed ID: 31413268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of
    Semenishchev VS; Nedobukh TA; Voronina AV; Kirichenko IV; Malyshev AS; Kirillov EV
    Appl Radiat Isot; 2020 Dec; 166():109382. PubMed ID: 32877864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear data for reactor production of
    Kulage Z; Cantrell T; Griswold J; Denton D; Garland M; Copping R; Mirzadeh S
    Appl Radiat Isot; 2021 Jun; 172():109645. PubMed ID: 33689941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An electrochemical generator for the continual supply of
    Forrester R; Dutech G; Akin A; Fassbender ME; Mastren T
    Nucl Med Biol; 2024; 136-137():108941. PubMed ID: 39002499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential production of Ac-225 at Egyptian second research reactor (ETRR-2) through neutron induced transmutation of Ra-226.
    Gizawy MA; Mohamed NMA
    Appl Radiat Isot; 2024 Mar; 205():111176. PubMed ID: 38217940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclotron and linac production of Ac-225.
    Melville G; Allen BJ
    Appl Radiat Isot; 2009 Apr; 67(4):549-55. PubMed ID: 19135381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.
    Bruchertseifer F; Kellerbauer A; Malmbeck R; Morgenstern A
    J Labelled Comp Radiopharm; 2019 Sep; 62(11):794-802. PubMed ID: 31369165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
    Kozempel J; Mokhodoeva O; Vlk M
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of activation cross sections of double neutron capture reaction on
    Madumarov AS; Aksenov NV; Bozhikov GA; Astakhov AA; Albin YV; Bulavin MV; Shabalin EP; Dmitriev SN
    Nucl Med Biol; 2024; 134-135():108928. PubMed ID: 38776715
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Koniar H; Wharton L; Ingham A; Rodríguez-Rodríguez C; Kunz P; Radchenko V; Yang H; Rahmim A; Uribe C; Schaffer P
    Phys Med Biol; 2024 Jul; 69(15):. PubMed ID: 38925140
    [No Abstract]   [Full Text] [Related]  

  • 37. Actinium-225 targeted alpha particle therapy for prostate cancer.
    Bidkar AP; Zerefa L; Yadav S; VanBrocklin HF; Flavell RR
    Theranostics; 2024; 14(7):2969-2992. PubMed ID: 38773983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes.
    Hassan M; Bokhari TH; Lodhi NA; Khosa MK; Usman M
    Chem Biol Drug Des; 2023 Nov; 102(5):1276-1292. PubMed ID: 37715360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed Chemistry Studies of
    Eryilmaz K; Kilbas B
    Curr Radiopharm; 2022; 15(1):76-83. PubMed ID: 34053430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhodium self-powered neutron detector as a suitable on-line thermal neutron flux monitor in BNCT treatments.
    Miller ME; Sztejnberg ML; González SJ; Thorp SI; Longhino JM; Estryk G
    Med Phys; 2011 Dec; 38(12):6502-12. PubMed ID: 22149833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.